DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Wang HJ, Park JY, Kwon O. , et al.
Chronic HMGCR/HMG-CoA reductase inhibitor treatment contributes to dysglycemia by upregulating hepatic gluconeogenesis through autophagy induction.
Autophagy 2015;
11 (11) 2089-2101
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.